News

Johnson & Johnson to pay $72M in talcum powder-related cancer case. For parents who chose to use the cornstarch-based baby powder, which has larger particles and is not believed to be as harmful ...
Companies that make talc-based powder have faced thousands of lawsuits about their products. Johnson & Johnson stopped selling talc-based baby powder in 2020. The company has denied any cancer link.
Johnson & Johnson has argued in court that studies haven’t found a convincing link between ovarian cancer and talc powder. A new analysis suggests they are indeed associated.
Lawsuits related to J&J’s talc-based baby powder date back to 1999, when a woman alleged that a lifetime of using it led to her mesothelioma, a rare cancer usually caused by exposure to asbestos ...
Talc is not banned in the U.S., but today, many baby powder brands instead use cornstarch, which is used as an absorbent in cosmetics. While cornstarch is likely a safer choice than talc, some ...
Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of ...
The World Health Organization's (WHO) cancer research agency has delivered a damning report on powdered mineral talc, calling it "probably" cancer-causing to humans, mainly because of powders ...
Johnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of lawsuits claiming it had caused cancer.
Johnson & Johnson said Tuesday that it will offer at least $8.9 billion to resolve thousands of lawsuits filed by people alleging that the company's products containing talc caused cancer ...
The talc litigation dates to 2013, as women began to say that baby powder had made them sick. By 2017 they were alleging that talc contaminated by asbestos had given them ovarian cancer and ...
Johnson & Johnson on Tuesday said that it's ready to pay $8.9 billion over lawsuits regarding its talc-based baby powder, a move the company hopes will resolve claims and suits over the product's ...